For many years, all types of DCIS have been given the same SOC treatment options. The guidelines state that standard treatment still involves surgical removal of the abnormal cells, even though researchers are exploring whether some low-risk cases may not require aggressive treatment. Recommended options include lumpectomy with or without radiation, mastectomy in certain cases, and endocrine therapy such as tamoxifen for estrogen receptor–positive DCIS. 

Both patients and physicians have had concerns about overtreatment. This has led to controversies, debates, conferences, and research including “Active Monitoring” for low-risk DCIS.

DCIS 411 is the only patient-focused website helping women navigate the challenges when questioning SOC treatments and seeking a more individualized approach to long-term cancer-free health.

DCIS 411 has been at the forefront of advocating for change. See the following posts:

What is “Low-risk” DCIS & Why is The COMET Study Urgently Needed?

DCIS — Beyond “One-Size Fits-All”

Why the “Standard of Care” Must Change

What Women Today Need to Know if Diagnosed with DCIS

DCIS is massively over-treated. Over-treatment equals extreme harm physically, emotionally, spiritually and financially.  Today, women must decide for themselves if they will go along with the “standard of care” because it is “policy” or if they will educate themselves, get more precise information on their individual case and make treatment and lifestyle decisions based on facts not fear.